Leader Spotlight: Turning mission into momentum for pet health, with Dr. Steve Weinrauch, BVMS, MRCVS
Dr. Steve Weinrauch is Chief Product and Veterinary Officer at Trupanion, the leading provider of pet medical insurance in North America. He is also the Founder of MightyVet 501(c)(3). A licensed veterinarian in both the U.S. and EU, Steve has published in peer-reviewed journals and brings over two decades of experience across veterinary practice, hospital operations, and product innovation.
In our conversation, Dr. Weinrauch explains how Trupanion’s real-time payment technology evolved into the Pet and Public Health Early Warning and Detection System. He discusses the challenges of structuring claims data for disease surveillance, trade-offs in designing for multiple stakeholders, and strategies for building adoption. He also shares lessons for product leaders creating data-driven platforms, how to measure mission-first success, and his vision for scaling the system globally.
Building the foundation for early detection
To provide some context for our conversation, could you start by giving an overview of the Pet and Public Health Early Warning and Detection System and share how it came about?
Our original objective was to solve a problem nobody in our industry had yet figured out: the reimbursement challenge in pet medical insurance. We recognized that the traditional model wasn’t just inconvenient; it was a significant barrier to care. It forces pet parents to pay the vet’s bill in full upfront and wait weeks for reimbursement — that may or may not ever arrive — causing financial stress or worse, compromising their pet’s care. For veterinary practices, it adds cumbersome paperwork and shifts the focus from medicine to costs — ultimately, creating an unsustainable system of care.
We knew we had to provide pet parents and vets with a real solution, so we deliberately allocated substantial resources and years of development to build a foundational technology that would transform the industry. The result was our patented Veterinary Portal, an award-winning platform that automates claims and enables real-time, direct payment to practices.
This technology is really what sets us apart today. We began using sophisticated machine learning for claims as early as 2016, long before anyone was discussing “AI” processing. We were the first to offer a real solution to the reimbursement model, and we remain the only pet insurer in North America with the ability to pay claims directly to practices at the time of checkout. This significant head start means our claims method is truly leading-edge—it’s been thoroughly tried and tested—and has advanced capabilities that, now, can extend to broader uses, like zoonotic disease surveillance.
The concept of the system gained momentum, though, during COVID-19, when pet parents and veterinarians turned to us with concerns about potential risks to animals and their families. This exposed a critical gap in both human and animal healthcare: despite the “One Health” principle linking the two, no advanced system existed to track emerging diseases in pets or facilitate collaboration between public and private sectors. It was then that we saw the potential to adapt our proven technology to serve a broader public good — leveraging millions of real-time pet insurance claims to reveal disease patterns not previously possible.
In practice, the system would operate in the background, automatically collecting anonymized data from every connected clinic to detect subtle, early indicators of disease that might otherwise go unnoticed. By combining this companion animal data with human and livestock health information, it could help determine whether a single cough in a puppy might be part of a larger outbreak. This level of early detection could help us identify and contain threats before they spread.
Real-time insurance claims data is not traditionally used as an early detection signal for disease. Can you talk through some of the decisions you may have to make in turning that raw data into structured, usable insights?
You’re right - it’s not traditional, and that’s part of the challenge we set out to address. While claims data is rich in information, it’s not inherently structured for disease surveillance. The key early decisions will focus on data architecture and algorithm design to transform large volumes of unstructured data into usable insights.
Before our advanced machine learning and AI can extract meaningful patterns, the data must be normalized and anonymized. From there, the goal is to develop frameworks to correlate subtle symptoms with factors like breed, age, and location to surface potential early signals of disease.
For example, a spike in claims for “fever” and “seizures” in cats within a specific region might not be flagged by a simple search, but a sophisticated model could detect the correlation and flag it as an emerging signal — similar to what we found retroactively with a past canine influenza outbreak. Looking back, our data had identified early signs — fevers and respiratory issues — before the outbreak was even recognized. That was a pivotal moment, showing us we needed to invert the model: instead of waiting for questions, we should deliver answers before anyone knows to ask.
Measuring impact beyond revenue
How do you measure success for a product like this that is more mission- than revenue- driven?
At its core, the product is about creating a safer world for all. So, measuring success goes beyond traditional revenue metrics. While the technology is a long-term strategic asset that builds trust in our company by solving a problem for veterinary professionals and pet parents alike and, by extension, drives revenue, its primary measure of success is its impact on the broader ecosystem. Did the system provide a critical head start on a potential outbreak? Did our data enable a laboratory to accelerate vaccine R&D, or help the CDC issue faster public health alerts? Are more pets living longer, healthier lives because of early warnings and better diagnostics?
For us, success isn’t just about the bottom line. It’s about living our mission and staying true to our “why.” Sure, the system embodies a commitment to the “One Health” philosophy, but it also proves that a for-profit company can and should contribute to public good. Doing the right thing has always been the best long-term strategy for our business, and it’s a big reason we are the leading pet insurer in North America today.
What potential tradeoffs did you have to make to design a product that could meet the different needs of multiple user groups (e.g., veterinarians, data scientists, regulators)?
From the start, our biggest tradeoffs were in resource allocation and prioritization. Developing our Vet Portal cost close to $30 million and took years to perfect. We could have invested these resources in marketing or other areas of our business that drove short-term revenue, but we made a deliberate choice. Without that foundational technology, we couldn’t create something truly transformational. It was a necessary sacrifice to build a robust, 24/7/365 claims processing system capable of real-time payments, that now lays the foundation for a public health system that benefits everyone.
For different user groups, the trade-offs now center on balancing features. For veterinarians, the system must be seamless and non-intrusive so they can focus on medicine. For data scientists, the data must be anonymized, structured, and robust enough for complex analysis. For regulators, it must be transparent and compliant. The core design decision will focus on a single, powerful data source — our real-time companion animal data — and from there, it will be tailored to meet each group’s needs. It’s about creating synergy where none existed before, made possible by the hard choice to do the right thing from the outset.
Earning trust in the veterinary community
Veterinary clinics are not always early adopters of technology. Can you share some strategies you used to build awareness, trust, and adoption of the Pet and Public Health Early Warning and Detection System within the veterinary community?
The beauty of this system is that it’s an added benefit to a product they already love and use every day. We don’t ask them to do anything new – rather, empower them by turning a routine task, like getting paid, into a vital part of the global public health effort.
From the start, we built credibility by assembling a coalition of global thought leaders — from the CDC to veterinary associations like the AVMA, pharmaceutical manufacturers like Boehringer Ingelheim, global non-profits including Morris Animal Foundation, and lab partners such as MARS Science & Diagnostics. These partnerships brought immediate credibility and trust throughout the entire veterinary ecosystem. We didn’t presume to have all the answers; instead, we facilitated conversations and let experts lead in their areas. Through webinars and other educational materials, we showed the community how our technology could bridge worlds and address a shared problem.
When you’re solving meaningful challenges — like reimbursement in pet health insurance and data-sharing gaps — you don’t need a hard sell. You just need to show the way, and that’s what we continue to do.
Crossing boundaries with purpose
This system is a rare example of a product that operates at the intersection of real-time data, public health, and private industry. What core lessons would you share with other product leaders trying to build impactful solutions that cross these boundaries?
Before you build anything, you have to understand your core purpose — your “why.” For us, that is protecting pets and their families.
Beyond that, the key is to build relationships, not just products. You have to ask a lot of questions to understand the landscapes and ecosystems of your potential partners. What’s their “why?” What are their biggest challenges? What red tape do they have to deal with? Who are their constituents? You can build a solution, but if there are barriers to adoption, you won’t get very far. So, you need to know those obstacles well and consciously create a product that removes them.
For us, we knew that the real opportunity, the truly great work, was at the intersection of these complex worlds – pet health data, public health, private industry. The key was to ask a different kind of question: not, “How do we get a piece of this market?” but, “How do we bring these worlds together to create a better future?” There’s no power in building a product in a vacuum. Real power comes from a strategic network, where everyone benefits from the same product — in this case, data — allowing us to find solutions together that we couldn’t find alone. The system provides a neutral ground and the technology to do that.
What lessons can other digital product leaders take from your experience when it comes to building trust in data-driven, multi-party platforms?
A truly great product shouldn’t need a hard sell. Don’t bring something to market for quick revenue; embed your “why” into development and invest in what will set you apart long-term, even if that means sacrificing temporary growth elsewhere.
Look beyond the product’s primary function and immerse yourself in the end-user’s world. Understand your partners, their stakeholders, and the barriers they face now and in the future. When you create something connected to a higher purpose — a real solution that transcends sectors and even species — trust becomes a natural byproduct.
Turning mission into momentum
How do you define long-term success in this kind of product, especially when you’re trying to solve problems that ideally never happen?
That’s an important question, and one we hear often — usually from a traditional perspective that assumes we’re building a system to solve a single problem. In reality, our mission is much broader: to change the world for pets and the people who love them.
Long-term success isn’t measured solely by the number of disasters we’ve prevented. Our goal is to preserve the human-animal bond. If pets are living longer, healthier lives, we’ve succeeded. That means families stay together longer, and people can welcome pets into their lives without the constant worry of financial strain.
Our data supports this: Trupanion pets live longer than those not on our plan. That’s not by chance — it’s the result of helping remove the financial barriers that too often force heartbreaking choices at the veterinarian’s office.
While some may think our focus is financial, the truth is the opposite. Financial success is a byproduct of doing the right thing. When we help a pet live longer, that pet stays with us longer. When we pay the bill in real time, we earn trust that drives referrals. It’s a virtuous business model.
And it extends beyond pets. Supporting an animal’s health benefits the human’s health, too. We see it every day: a pet gives an aging family member purpose, encourages daily walks, and keeps hearts healthy. Yes, we are a pet health insurance company, but our product and technology protect one of the most important relationships in people’s lives.
How do you see the system evolving?
Our long-term vision is both simple and ambitious: to move beyond North America and parts of Continental Europe to a truly global presence. Success will be when this level of care and security is accessible to pet parents everywhere.
What does LogRocket do?
LogRocket’s Galileo AI watches user sessions for you and surfaces the technical and usability issues holding back your web and mobile apps. Understand where your users are struggling by trying it for free at LogRocket.com.